Beacon Capital Management LLC (Tennessee)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-607
Closed -$65.2K 248
2025
Q2
$65.2K Hold
607
0.01% 285
2025
Q1
$61.2K Sell
607
-5
-0.8% -$503 0.01% 282
2024
Q4
$54.7K Sell
612
-61
-9% -$5.37K 0.01% 291
2024
Q3
$56.4K Hold
673
0.01% 305
2024
Q2
$51.8K Buy
673
+97
+17% +$7.1K 0.01% 283
2024
Q1
$39.5K Buy
576
+571
+11,420% +$36.7K 0.01% 338
2023
Q4
$264 Hold
5
﹤0.01% 948
2023
Q3
$270 Hold
5
﹤0.01% 987
2023
Q2
$270 Hold
5
﹤0.01% 987
2023
Q1
$250 Buy
+5
New +$236 ﹤0.01% 912
2022
Q3
Sell
-125
Closed -$6K 884
2022
Q2
$6K Hold
125
﹤0.01% 596
2022
Q1
$6K Buy
+125
New +$5.42K ﹤0.01% 596

Other funds holding BSX

Beacon Capital Management LLC (Tennessee)'s BSX Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 607 shares — an estimated $65.2K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in BSX in Q1 2022 and held it in 12 quarters. The position peaked at $65.2K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 607 Boston Scientific shares in Q3 2025, an estimated $65.2K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Boston Scientific in Q1 2022 and held it in 12 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Boston Scientific position peaked at $65.2K in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.